Clinical Trials Sponsored by Kinderwunsch Institut GmbH

Total 441 results

Kinderwunsch Institut GmbH
Institut AllergoSan

Completed

Influence of Probiotics on the Vaginal Microbiota

Vaginal Microbiome

Austria
Kinderwunsch Institut GmbH
Merck Sharp & Dohme LLC

Completed

Corifollitropin Alfa and Embryo Morphokinetics

Infertility

Austria
Institut fur Diabetes Karlsburg GmbH
Aktivmed GmbH; Beurer GmbH; IME-DC GmbH; Medisana GmbH

Completed

System Accuracy of 12 Bloog Glucose Monitoring Systems

Diabetes Mellitus

Germany
Ecarf Institute GmbH
Bencard Allergie GmbH

Completed

Long-term Effect of a 3-month Supplementation With Holo-BLG on House Dust Mite Induced Allergic Rhinoconjunctivitis

Allergic Rhinitis | Dust Mite Allergy

Germany
Ecarf Institute GmbH
Bencard Allergie GmbH

Completed

Impact of a Novel Immune Modulating Dietary Supplement on House Dust Mite Induced Allergic Rhinoconjunctivitis

Allergic Rhinitis | Dust Mite Allergy

Germany
Institut fur Diabetes Karlsburg GmbH
Beurer GmbH

Completed

System Accuracy of BGM GL60

Diabetes Mellitus

Germany
Institut fur Diabetes Karlsburg GmbH
Beurer GmbH

Completed

System Accuracy of a Blood Glucose Monitoring System GlucoSpark/GlucoScore

Diabetes Mellitus

Germany
Allergy Therapeutics
Ecarf Institute GmbH; Bencard Allergie GmbH

Completed

Effect of holoBLG on Cat Allergic Patients

Allergic Rhinoconjunctivitis | Allergy to Cats

Germany
Helios Health Institute GmbH

Recruiting

The Leipzig TAVI Registry

Aortic Valve Stenosis

Germany
Leipzig Heart Institute GmbH

Not yet recruiting

Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death (PROFID-Reduced)

Myocardial Infarction | Heart Failure | Sudden Cardiac Death
Beneo-Institute
BioTeSys GmbH

Completed

Investigation of Blood Glucose and Insulin Response After Intake of Vitalose

Healthy Adults

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Thoraxklinik-Heidelberg gGmbH

Active, not recruiting

Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease (TREASURE)

Thoracic Radiotherapy | Small Cell Lung Cancer Extensive Stage

Germany, Austria
Leipzig Heart Institute GmbH

Not yet recruiting

Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death

Myocardial Infarction | Sudden Cardiac Death
Helios Health Institute GmbH

Completed

Prevalence and Predictors of Esophageal Thermal Lesions in High-power-Short-duration Ablation of Atrial Fibrillation (VISUAL-AF)

Atrial Fibrillation | Esophagus Injury

Germany
Leipzig Heart Institute GmbH

Completed

Randomized Comparison of Catheter-based Strategies for Interventional Access Site Closure During Transfemoral Transcatheter Aortic Valve Implantation (CHOICE-CLOSURE)

Aortic Valve Stenosis

Germany
Leipzig Heart Institute GmbH

Completed

Fasting Versus Non-Fasting for Cardiac Implantable Electronic Devices (FastCIED Study)

Cardiac Implantable Electronic Devices

Germany
Helios Health Institute GmbH

Recruiting

The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases (H²-Registry)

Coronary Artery Disease | Heart Failure | Atrial Fibrillation

Germany
Leipzig Heart Institute GmbH

Suspended

Effect of Multielectrode Versus Point-by-Point Mapping on Recurrence of Ventricular Tachycardia in Ischemic Heart Disease (EMPIRE-VT)

Ventricular Tachycardia

Germany
AvenCell Europe GmbH
PHARMALOG Institut für klinische Forschung GmbH

Recruiting

Dose-escalating Trial With UniCAR02-T Cells and CD123 Target Module (TM123) in Patients With Hematologic and Lymphatic Malignancies

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | Acute Myeloid Leukemia (AML)

Germany
AvenCell Europe GmbH
PHARMALOG Institut für klinische Forschung GmbH

Terminated

Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker

Prostate Cancer

Germany
Helios Health Institute GmbH
Heart Center Leipzig - University Hospital; IHF GmbH - Institut für Herzinfarktforschung

Active, not recruiting

Extracorporeal Life Support in Cardiogenic Shock (ECLS-SHOCK)

Acute Myocardial Infarction | Cardiogenic Shock

Germany
Institut fuer Frauengesundheit
Eisai GmbH

Recruiting

Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)

Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, Breast

Germany
IHF GmbH - Institut für Herzinfarktforschung

Recruiting

Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study

Coronary Disease

Germany
Profil Institut für Stoffwechselforschung GmbH

Active, not recruiting

Clinical Experimental Study to Investigate Specific Features of ClampArt®

Diabetes Mellitus

Germany
Institut fur Diabetes Karlsburg GmbH

Completed

User Evaluation of BGM JS200B

Diabetes

Germany
Institut fur Diabetes Karlsburg GmbH

Enrolling by invitation

System Accuracy of 14 Blood Glucose Monitoring Systems

Diabetes

Germany
IHF GmbH - Institut für Herzinfarktforschung

Completed

Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes (Real-TICA)

Acute Coronary Syndrome (ACS)

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment

Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1

Diabetes Mellitus

Germany
ISAR-M GmbH
CRI-The Clinical Research Institute GmbH

Not yet recruiting

Thyroid HEmorrhage DetectOr Study (HEDOS)

Thyroid
Institut fur Diabetes Karlsburg GmbH

Completed

User Evaluation of BGM VGM77

Diabetes

Germany
Profil Institut für Stoffwechselforschung GmbH

Terminated

Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion

Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain

Diabetes Mellitus

Germany
Institut fur Diabetes Karlsburg GmbH

Not yet recruiting

System Accuracy of the Blood Glucose Monitor for Personal Use Contour Care

Diabetes

Germany
IHF GmbH - Institut für Herzinfarktforschung

Not yet recruiting

BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation

Emphysema or Chronic Obstructive Pulmonary Disease

Germany
IHF GmbH - Institut für Herzinfarktforschung

Recruiting

Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes

Heart Failure

Germany
Institut fur Diabetes Karlsburg GmbH

Completed

System Accuracy of BGM GL22

Diabetes

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes Mellitus (DLW)

Diabetes

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Explorative Assessment of Biomarkers in Overweight and Obese Subjects

Prediabetes

Germany
Institut fur Diabetes Karlsburg GmbH

Completed

Blood Glucose Monitoring Systems: Discounter Versus Brand

Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Empagliflozin and Sympathetic Nerve Traffic

Type 2 Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test (DXM2)

Type 2 Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Withdrawn

An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms

Diabetes Type 1 | Prediabetes | Diabetes Type 2
Profil Institut für Stoffwechselforschung GmbH

Completed

Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology

Type 2 Diabetes Mellitus

Germany
Institut für Klinische Krebsforschung IKF GmbH...
AstraZeneca; Thoraxklinik-Heidelberg gGmbH

Recruiting

Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy (TRADE-hypo)

NSCLC, Stage III

Germany
AIO-Studien-gGmbH
Servier; Institut für Klinisch-Onkologische Forschung der Krankenhaus Nordwest...

Active, not recruiting

Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer (NIFE)

Biliary Tract Cancer | Extrahepatic Bile Duct Carcinoma | Non-Resectable Hepatocellular Carcinoma | Adenocarcinoma Metastatic | Adenocarcinoma of the Biliary Tract | Adenocarinoma Locally Advanced | Intrahepatic Bile Duct Carcinoma

Germany
Fresenius Medical Care Deutschland GmbH
Institut Dr. Schauerte GmbH (IDS)

Completed

Comparison of Clinical Performance and Hemocompatibility of Dialyzers Applied During Post-dilution Online Hemodiafiltration (eMPORAIII)

Renal Failure | End Stage Renal Disease

Germany, Czechia, Hungary
cerbomed GmbH
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

Completed

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia (02VNS2009)

Schizophrenia

Germany
Otsuka Frankfurt Research Institute GmbH

Unknown

Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

SIADH | Non-SIADH Hyponatremia | Non-Hyponatremia

Denmark, Germany, Italy, Norway, Spain, Sweden, United Kingdom
Otsuka Frankfurt Research Institute GmbH

Completed

ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis

Ulcerative Colitis

Clinical Trials Sponsored by Kinderwunsch Institut GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations